Burlingame, CA, Aug. 28, 2025 (GLOBE NEWSWIRE) — The Global Vitamin D Therapy Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032. This significant growth redirects growing awareness about vitamin D deficiency and its impact on health, increased prevalence of related disorders, and advancements in therapy options. Market increase is driven by growing demand across various age groups and geographic regions. Key trends shaping the vitamin D therapy market include the growing emphasis on personalized medicine and the expanding use of digital health tools to monitor vitamin D levels. The industry is also experiencing a shift toward innovative formulations and delivery systems aimed at improving bioavailability and patient adherence.
Request a Sample Copy of this Report at: https://www.coherentmarketinsights.com/insight/request-sample/8475
Global Vitamin D Therapy Market Key Takeaways
According to Coherent Market Insights (CMI), the global vitamin D market size is expected to more than double during the forecast period, reaching USD 5.62 Bn by 2032, up from USD 2.64 Bn in 2025.
Global vitamin D therapy demand is slated to increase at a CAGR of 11.3% between 2025 and 2032.
Over-the-counter (OTC) drugs are anticipated to remain a highly sought-after type, accounting for 58.2% of the global vitamin D therapy market share in 2025.
Based on route of administration, oral segment dominates the industry, capturing more than three-fourths of the global market by 2025.
Tablets, with an estimated market share of nearly one-third in 2025, are expected to remain the most preferred dosage form.
North America is set to maintain its dominance, accounting for nearly two-fifths of the global vitamin D therapy market revenue share in 2025.
Asia Pacific is expected to become a highly lucrative pocket for vitamin D therapy companies during the projection period.
Increasing Incidence of Vitamin D Deficiency Fueling Market Growth
Coherent Market Insights’ latest vitamin D therapy market analysis outlines major factors driving market growth. One such key growth driver is the rising incidence of vitamin D deficiency.
Vitamin D deficiency is becoming a significant global public health issue, affecting millions of people worldwide. According to the GrassrootsHealth Nutrient Research Institute, about two-thirds of Americans have insufficient vitamin D levels.
This widespread vitamin D insufficiency is increasing demand for supplementation and therapy. It will create a conducive environment for the expansion of vitamin D therapy market during the assessment period.
Vitamin D therapy is widely used to correct deficiency and maintain calcium and phosphate absorption for bone and muscle health. Thus, as cases of vitamin D deficiency rise, so will demand for vitamin D therapy.
Purchase Now Up to 25% Discount on This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/8475
Risk of Overdose and Alternative Nutrient Sources Limiting Market Growth
The global vitamin D therapy market outlook looks bright due to rising awareness of vitamin D deficiency and its health risks. However, market growth in some regions could slow down because of the risk of overdose and rising usage of alternative nutrient sources.
Excessive vitamin D intake can lead to hypervitaminosis D, causing side effects such as nausea as well as kidney stones. This may deter consumers from widespread use, dampening vitamin D therapy market demand.
Likewise, many consumers are opting for fortified foods and supplements to address vitamin D deficiency. This might also hamper the vitamin D therapy market growth during the assessment period.
Rising Geriatric Population …